FDA medical product approvals: hearing before the Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, first session, August 8, 1995
United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs
U.S. Government Printing Office, 1997 - Political Science - 55 pages
44 pages matching FDA reform in this book
Results 1-3 of 44
What people are saying - Write a review
We haven't found any reviews in the usual places.
agency American patients angioplasty Barlow Foods benefit Cardiologists Chairman CLIA clinical trial Committee Congress coronary arteries coronary investigator Corrections Day costs create defibrillator DENNIS HASTERT device approval device manufacturers drug Europe example FDA approval FDA reform Federal regulation field hearing Geier GIL GUTKNECHT going Gutknecht HCFA HCFA's healthcare hospital implanted improve ingredient issue JOE SCARBOROUGH labeling life-threatening look LOUISE McINTOSH SLAUGHTER masks Mayo Clinic MclNtOSh medical device industry medical innovation medical research medical technologies Medicare Medtronic MICHAEL MURPHY Minnesota Medical Association Murphy Murray occluded office laboratories Olmsted Medical OSHA overly burdensome overseas pace PAP smear paperwork Paul Citron perform physicians problem procedures protect the public RANDY TATE record regulatory reimbursement resulted Rochester safe safety Schwartz senior citizens specific staff stent subcommittee testimony tests Thank therapy things United Vetter witnesses